help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2006-1741
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
148/8/3958    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boyd, C.
Right arrow Articles by Náray-Fejes-Tóth, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boyd, C.
Right arrow Articles by Náray-Fejes-Tóth, A.
Endocrinology Vol. 148, No. 8 3958-3967
Copyright © 2007 by The Endocrine Society

Steroid-Mediated Regulation of the Epithelial Sodium Channel Subunits in Mammary Epithelial Cells

Cary Boyd and Anikó Náray-Fejes-Tóth

Department of Physiology, Dartmouth Medical School, Lebanon, New Hampshire 03756

Address all correspondence and requests for reprints to: Anikó Náray-Fejes-Tóth, Department of Physiology, Dartmouth Medical School, Borwell Building 744W, 1 Medical Center Drive, Lebanon, New Hampshire 03756. E-mail: aniko.fejes-toth{at}dartmouth.edu.

The epithelial sodium channel (ENaC) is a key mediator of sodium transport in epithelia; however, little is known about ENaC expression in mammary epithelia. Using real-time PCR, we demonstrated the expression of the ENaC subunit mRNAs in mouse and human mammary cell lines and in vivo mouse mammary tissue. We determined the effects of glucocorticoids, progesterone, and prolactin on ENaC expression in four mammary cell lines. Dexamethasone induced all detectable ENaC subunits in noncancerous cell lines, HC11 and MCF10A. Interestingly, in cancerous cell lines (T-47D and MCF-7), both ß- and {gamma}- but not {alpha}ENaC mRNAs were induced by dexamethasone. Progesterone induced ENaC mRNA only in T-47D cells, and prolactin had no effects. {gamma}ENaC was rapidly induced by steroids, whereas induction of {alpha}- and ßENaC was slower; moreover, the induction of the ß-subunit required de novo protein synthesis. Dexamethasone treatment did not affect ENaC mRNA stability. Western blot analysis revealed immunoreactive bands corresponding to different forms of {alpha}-, ß-, and {gamma}ENaC; dexamethasone significantly increased the intensity of {alpha}ENaC (85 kDa) and ßENaC (90 kDa). We also showed an in vivo reduction in {alpha}ENaC levels in the mammary tissue of lactating mice as compared with controls, whereas ß- and {gamma}ENaC mRNA levels were significantly increased. Furthermore, dexamethasone in vivo significantly increased {alpha}-, ß-, and {gamma}ENaC mRNA expression. Our data indicate that both mouse and human mammary cells express all ENaC subunits, and they are regulated by steroid hormones in a temporal and cell-specific manner both in culture and in vivo.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society